S'abonner

Clinical and epidemiological performance of WHO Ebola case definitions: a systematic review and meta-analysis - 22/10/20

Doi : 10.1016/S1473-3099(20)30193-6 
Grazia Caleo, MD a, d, , Foivi Theocharaki, MSc b, Kamalini Lokuge, PhD a, c, Helen A Weiss, ProfPhD d, Leena Inamdar, MD e, Francesco Grandesso, MSc f, Kostas Danis, PhD g, Biagio Pedalino, DrPH h, i, Gary Kobinger, ProfPhD j, Armand Sprecher, MD k, Jane Greig, PhD a, Gian Luca Di Tanna, PhD l
a Manson Unit, Médecins sans Frontières, London, UK 
b Centre for Longitudinal Studies, University College London, London, UK 
c National Centre for Epidemiology and Population Health, Research School of Population Health, Australian National University, Canberra, ACT, Australia 
d MRC Tropical Epidemiology Group, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, UK 
e Public Health England, Leeds, UK 
f Epicentre, Paris, France 
g Santé Publique France, Saint-Maurice, France 
h TEPHINET, Task Force for Global Health, Decatur, GA, USA 
i Istituto Superiore Di Sanita, Rome, Italy 
j Département de Microbiologie-Infectiologie et d’Immunologie, Université Laval, Quebec City, QC, Canada 
k Médecins sans Frontières, Brussels, Belgium 
l The George Institute for Global Health, University of New South Wales, Sydney, NSW, Australia 

* Correspondence to: Dr Grazia Caleo, Manson Unit, Médecins sans Frontières, London EC4A 1AB, UK Manson Unit Médecins sans Frontières London EC4A 1AB UK

Summary

Background

Ebola virus disease case definition is a crucial surveillance tool to detect suspected cases for referral and as a screening tool for clinicians to support admission and laboratory testing decisions at Ebola health facilities. We aimed to assess the performance of the WHO Ebola virus disease case definitions and other screening scores.

Methods

In this systematic review and meta-analysis, we searched PubMed, Scopus, Embase, and Web of Science for studies published in English between June 13, 1978, and Jan 14, 2020. We included studies that estimated the sensitivity and specificity of WHO Ebola virus disease case definitions, clinical and epidemiological characteristics (symptoms at admission and contact history), and predictive risk scores against the reference standard (laboratory-confirmed Ebola virus disease). Summary estimates of sensitivity and specificity were calculated using bivariate and hierarchical summary receiver operating characteristic (when four or more studies provided data) or random-effects meta-analysis (fewer than four studies provided data).

Findings

We identified 2493 publications, of which 14 studies from four countries (Sierra Leone, Guinea, Liberia, and Angola) were included in the analysis. 12 021 people with suspected disease were included, of whom 4874 were confirmed as positive for Ebola virus infection. Six studies explored the performance of WHO case definitions in non-paediatric populations, and in all of these studies, suspected and probable cases were combined and could not be disaggregated for analysis. The pooled sensitivity of the WHO Ebola virus disease case definitions from these studies was 81·5% (95% CI 74·1–87·2) and pooled specificity was 35·7% (28·5–43·6). History of contact or epidemiological link was a key predictor for the WHO case definitions (seven studies) and for risk scores (six studies). The most sensitive symptom was intense fatigue (79·0% [95% CI 74·4–83·0]), assessed in seven studies, and the least sensitive symptom was pain behind the eyes (1·0% [0·0–7·0]), assessed in three studies. The performance of fever as a symptom varied depending on the cutoff used to define fever.

Interpretation

WHO Ebola virus disease case definitions perform suboptimally to identify cases at both community level and during triage at Ebola health facilities. Inclusion of intense fatigue as a key symptom and contact history could improve the performance of case definitions, but implementation of these changes will require effective collaboration with, and trust of, affected communities.

Funding

Médecins sans Frontières.

Le texte complet de cet article est disponible en PDF.

Plan


© 2020  Elsevier Ltd. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 20 - N° 11

P. 1324-1338 - novembre 2020 Retour au numéro
Article précédent Article précédent
  • Changes in epilepsy burden after onchocerciasis elimination in a hyperendemic focus of western Uganda: a comparison of two population-based, cross-sectional studies
  • Nolbert Gumisiriza, Christoph Kaiser, George Asaba, Henry Onen, Frank Mubiru, Donozio Kisembo, Joseph Nelson Siewe Fodjo, Robert Colebunders
| Article suivant Article suivant
  • Burden of disease in Gabon caused by loiasis: a cross-sectional survey
  • Luzia Veletzky, Jennifer Hergeth, Daniel R Stelzl, Johannes Mischlinger, Rella Zoleko Manego, Ghyslain Mombo-Ngoma, Matthew B B McCall, Ayôla A Adegnika, Selidji T Agnandji, Wolfram G Metzger, Pierre B Matsiegui, Heimo Lagler, Benjamin Mordmüller, Christine Budke, Michael Ramharter

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.